Incidence of stroke and seizure in Alzheimer's disease dementia.

BACKGROUND the objective of the study was to estimate and compare the incidence rates of ischaemic and haemorrhagic stroke and seizure among cohorts with and without Alzheimer's disease (AD) dementia. METHODS we conducted a retrospective cohort study using electronic medical records (EMRs) from primary care practices that participated in The Health Improvement Network (THIN) in the United Kingdom from 1 January 1990 to 31 July 2009. For each AD-dementia patient, we selected one general population control patient without AD-dementia matched to one AD-dementia patient on year of birth, sex and physician practice. FINDINGS the AD-dementia cohorts were 68% female and averaged 80 years of age at the start of follow-up. Populations for analysis included 19,902 AD-dementia and matched non-AD-dementia patients with no history of stroke at baseline in which 790 incident cases of stroke occurred, and similarly, 22,084 AD-dementia and matched patients with no history of seizure at baseline in which 286 cases of seizure occurred. After adjusting for risk factors for each outcome, hazard ratios comparing AD-dementia with non-AD-dementia patients indicated higher rates among AD-dementia patients for stroke (HR = 1.29, 95% CI 1.11, 1.50) and seizure (HR = 5.31, 95% CI 3.97, 7.10). For stroke and seizure, the incidence rate ratios comparing AD-dementia patients with non-AD-dementia controls were greatest for the younger age groups. AD-dementia was observed to be a risk factor for both haemorrhagic stroke and seizures. Increasing age was associated with a decrease in relative risk and an increase in absolute risk.

[1]  Y. Kuo,et al.  Cerebrovascular pathology and amyloid plaque formation in Alzheimer's disease. , 2014, Current Alzheimer research.

[2]  H. Chiou,et al.  Alzheimer disease and risk of stroke , 2013, Neurology.

[3]  H. Soininen,et al.  Incidence of stroke in people with Alzheimer disease , 2013, Neurology.

[4]  R. Lipton,et al.  Contribution of vascular pathology to the clinical expression of dementia , 2010, Neurobiology of Aging.

[5]  P. Scheltens,et al.  Vascular Care in Patients With Alzheimer Disease With Cerebrovascular Lesions Slows Progression of White Matter Lesions on MRI: The Evaluation of Vascular Care in Alzheimer's Disease (EVA) Study , 2010, Stroke.

[6]  K. Jellinger Prevalence and Impact of Cerebrovascular Lesions in Alzheimer and Lewy Body Diseases , 2010, Neurodegenerative Diseases.

[7]  Hyunmi Choi,et al.  Seizures in Alzheimer disease: who, when, and how common? , 2009, Archives of neurology.

[8]  Frauke Zipp,et al.  The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases , 2006, Trends in Neurosciences.

[9]  Yaakov Stern,et al.  Incidence and Predictors of Seizures in Patients with Alzheimer's Disease , 2006, Epilepsia.

[10]  A. Drzezga,et al.  Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  K. Jellinger,et al.  Alzheimer disease and cerebrovascular pathology: an update , 2002, Journal of Neural Transmission.

[12]  J. C. de la Torre,et al.  Alzheimer Disease as a Vascular Disorder: Nosological Evidence , 2002, Stroke.